Search for a command to run...
Venus Remedies Ltd. presents a competitive valuation and solid growth metrics compared to its peers in the pharmaceuticals sector. While it has the lowest PE ratio along with strong cash flow metrics, some peers exhibit better profitability and growth. Companies like Mankind Pharma and Dr. Reddy's demonstrate superior growth, while Divi's Laboratories stands out for its profitability despite a high PE ratio.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
VENUSREM | ₹460.55 | ₹615.62Cr | 11.71 | 13.17% | 0.00 |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |